MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
iPierian Inc.
Finance & Acquisitions: iPerian
Parents
iPierian Inc.
Children
2010: Biopharmaceutical company, closed its Series B equity financing at $28 million.(2010)
2014: Bristol-Myers Squibb Acquires iPierian, Inc.
GlaxoSmithKline’s healthcare venture capital arm SR One, Biogen Idec New Ventures and other investors participated in this closi
Kleiner Perkins Caufield & Byers, MPM Capital, SR One, Biogen Idec New Ventures and Baxter Ventures participated in the Series A round, which includes proceeds from True North's spin-off from iPerian Inc. in 2013.
Venture backers have poured more than $50 million into the company (2011)
Venture backers include Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital, Google Ventures, GlaxoSmithKline’s SR One, FinTech Global Capital, Mitsubishi UFJ Capital, Mission Bay Capital, Atel Ventures, and Biogen Idec New Ventures
Jumps
Organization & Developments: iPerian